Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Frosst Canada Inc.

Division of Merck & Co. Inc.

Latest From Merck Frosst Canada Inc.

The Business Case For Post-Grant Patent Review

Counsels’ view of what inter parte reviews and other new procedures introduced by the America Invents Act mean to the biopharma industry.

BioPharmaceutical Legal Issues

With Partner Lilly, TVM Capital Gets A Canadian Makeover

One of two venture firms signed up to run an Eli Lilly “mirror portfolio” of single-asset companies, venerable TVM Capital has made significant changes to get its new model off the ground.


Bothering To Look: With New Tools, Biotech Goes Back To The Black Box

For decades drug discovery meant testing new compounds in cells and animals without knowing how or why they might work. A shift to reductionist, target-based discovery has done little to nothing to bring more drugs to market. Proponents say it’s time for more phenotypic inquiry early in the drug discovery process, bolstered when possible by better tools and technology.

BioPharmaceutical North America

Versant Ventures Looks To Canada, Europe For New Deals

Hoping to boost its international dealmaking, the California venture firm is setting up shop in Vancouver, BC, and expanding in Switzerland, to gain access to emerging projects that haven’t been “picked over.”

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Merck & Co. Inc.
  • Senior Management
  • Andre Marcheterre, Pres. & CEO
  • Contact Info
  • Merck Frosst Canada Inc.
    Phone: (514) 428-7920
    16711 Trans-Canada Hwy.
    Kirkland, H9H 3L1